Revvity, Inc.
Revvity, Inc.
Your view on RVTY
Overview
What the company does, where it operates, and who runs it.
About Revvity, Inc.
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Prahlad R. Singh
- Headquarters
- 940 Winter Street, Waltham, MA, US
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Prahlad R. Singh
- Headquarters
- 940 Winter Street, Waltham, MA, US
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics.
The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services.
It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil.
In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries.
The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions.
This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery.
It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies.
The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Revvity, Inc. from FRC's valuation model, read against the market price. RVTY last traded at $148.85, 66.2× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Revvity, Inc.. Starting points for Revvity, Inc.: P/E 66.2, EPS $2.27, beta 1.08 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Revvity, Inc.. Revvity, Inc. paid $0.28 per share over the last year — a 0.2% yield at the current $148.85 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Revvity, Inc.. Trailing twelve-month EPS for Revvity, Inc. stands at $2.27. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Revvity, Inc.. Revvity, Inc. has reported as a listed company since 1965. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
More Medical - Diagnostics & Research companies
Market cap
- ANPCFCellbxhealth PLCOTC$4M
- ARYCArrayit CorporationOTC$79,348
- AVCR.VAvricore Health Inc.TSXV$3M
- AVCRFAvricore Health Inc.OTC$6M
- BDSXBiodesix, Inc.NASDAQ$73M
- BDX.AXBCAL Diagnostics LimitedASX
- BIAFbioAffinity Technologies, Inc.NASDAQ$13M
- BIAFWbioAffinity Technologies, Inc.NASDAQ$5M
- BIOCQBiocept, Inc.OTC$263
- BIOQBioqual, Inc.OTC$34M
- BLLNBillionToOne, Inc.NASDAQ$4.6B
- BMKDFBioMark Diagnostics Inc.OTC$42M
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Revvity, Inc., and how their positions are changing. At a $16.62B market value, institutional positions materially move Revvity, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Revvity, Inc. executives and directors. Shares of Revvity, Inc. have traded between $81.36 and $128.29 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Revvity, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Revvity, Inc.. Coverage tracks Revvity, Inc. within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Revvity, Inc.